logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Mcdermott, James Richard
    Born in August 1968
    Individual (7 offsprings)
    Officer
    icon of calendar 1996-11-26 ~ now
    OF - Director → CIF 0
  • 2
    Underwood, David Douglas
    Born in August 1952
    Individual (6 offsprings)
    Officer
    icon of calendar 2002-06-17 ~ now
    OF - Director → CIF 0
    Mr David Douglas Underwood
    Born in August 1952
    Individual (6 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 3
    Herron, Neil Alec
    Born in May 1966
    Individual (5 offsprings)
    Officer
    icon of calendar 2021-01-01 ~ now
    OF - Director → CIF 0
Ceased 10
  • 1
    Jones, Nicholas Peter Mark
    Director born in June 1969
    Individual
    Officer
    icon of calendar 2000-02-01 ~ 2002-06-17
    OF - Director → CIF 0
    Jones, Nicholas Peter Mark
    Individual
    Officer
    icon of calendar 2000-02-01 ~ 2002-04-01
    OF - Secretary → CIF 0
  • 2
    Morgan, Alan Stuart
    Chief Operating Officer born in October 1964
    Individual (2 offsprings)
    Officer
    icon of calendar 2018-07-09 ~ 2020-09-30
    OF - Director → CIF 0
  • 3
    Hodgkins, Gillian Ann
    Individual
    Officer
    icon of calendar 1999-09-23 ~ 2000-02-01
    OF - Secretary → CIF 0
  • 4
    Coker, Linda Ann
    Individual
    Officer
    icon of calendar 2003-05-06 ~ 2007-04-27
    OF - Secretary → CIF 0
  • 5
    Macgarvey, Andrew James
    Director born in February 1968
    Individual (2 offsprings)
    Officer
    icon of calendar 2006-07-21 ~ 2011-11-25
    OF - Director → CIF 0
  • 6
    Chapple, Daniel Simon, Dr
    Commercial Director born in November 1973
    Individual (2 offsprings)
    Officer
    icon of calendar 2016-08-19 ~ 2021-02-17
    OF - Director → CIF 0
  • 7
    Mcdermott, Francis
    Business Consultant born in December 1942
    Individual (1 offspring)
    Officer
    icon of calendar 2006-12-21 ~ 2009-04-02
    OF - Director → CIF 0
  • 8
    Mcdermott, Anne Lydia
    Vascular Technician born in March 1966
    Individual (1 offspring)
    Officer
    icon of calendar 1996-11-26 ~ 1999-09-24
    OF - Director → CIF 0
    Mcdermott, Anne Lydia
    Individual (1 offspring)
    Officer
    icon of calendar 1996-11-26 ~ 1999-09-24
    OF - Secretary → CIF 0
  • 9
    Jones, Giorgio Andrew
    Management Accountant born in March 1961
    Individual (4 offsprings)
    Officer
    icon of calendar 2005-07-15 ~ 2016-02-22
    OF - Director → CIF 0
    Jones, Giorgio Andrew
    Individual (4 offsprings)
    Officer
    icon of calendar 2002-04-01 ~ 2003-05-06
    OF - Secretary → CIF 0
    icon of calendar 2007-04-27 ~ 2016-02-22
    OF - Secretary → CIF 0
  • 10
    icon of address26, Church Street, London
    Dissolved Corporate (4 parents, 9 offsprings)
    Equity (Company account)
    2 GBP2022-12-31
    Officer
    1996-11-26 ~ 1996-11-26
    PE - Nominee Secretary → CIF 0
parent relation
Company in focus

QUANTICATE INTERNATIONAL LIMITED

Previous name
OXFORD PHARMACEUTICAL SCIENCES LTD. - 2008-01-05
Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Administrative Expenses
-2,772,400 GBP2024-01-01 ~ 2024-12-31
-3,608,833 GBP2023-01-01 ~ 2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
84,229 GBP2024-01-01 ~ 2024-12-31
27,684 GBP2023-01-01 ~ 2023-12-31
Interest Payable/Similar Charges (Finance Costs)
-17,924 GBP2024-01-01 ~ 2024-12-31
-16,543 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
-845,267 GBP2024-01-01 ~ 2024-12-31
4,731,361 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-599,355 GBP2024-01-01 ~ 2024-12-31
3,620,032 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
-599,355 GBP2024-01-01 ~ 2024-12-31
3,620,032 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
Other than goodwill
700 GBP2024-12-31
3,127 GBP2023-12-31
Property, Plant & Equipment
20,547 GBP2024-12-31
49,724 GBP2023-12-31
Fixed Assets - Investments
48,404 GBP2024-12-31
48,404 GBP2023-12-31
Fixed Assets
69,651 GBP2024-12-31
101,255 GBP2023-12-31
Debtors
3,154,709 GBP2024-12-31
6,250,130 GBP2023-12-31
Cash at bank and in hand
6,178,853 GBP2024-12-31
4,892,185 GBP2023-12-31
Current Assets
9,333,562 GBP2024-12-31
11,142,315 GBP2023-12-31
Net Current Assets/Liabilities
6,569,817 GBP2024-12-31
7,127,811 GBP2023-12-31
Total Assets Less Current Liabilities
6,639,468 GBP2024-12-31
7,229,066 GBP2023-12-31
Net Assets/Liabilities
6,601,437 GBP2024-12-31
7,200,792 GBP2023-12-31
Equity
Called up share capital
2,000 GBP2024-12-31
2,000 GBP2023-12-31
2,000 GBP2022-12-31
Share premium
99,000 GBP2024-12-31
99,000 GBP2023-12-31
99,000 GBP2022-12-31
Other miscellaneous reserve
20 GBP2024-12-31
20 GBP2023-12-31
Retained earnings (accumulated losses)
6,500,417 GBP2024-12-31
7,099,772 GBP2023-12-31
7,479,740 GBP2022-12-31
Equity
6,601,437 GBP2024-12-31
7,200,792 GBP2023-12-31
Profit/Loss
Retained earnings (accumulated losses)
-599,355 GBP2024-01-01 ~ 2024-12-31
3,620,032 GBP2023-01-01 ~ 2023-12-31
Dividends Paid
Retained earnings (accumulated losses)
-4,000,000 GBP2023-01-01 ~ 2023-12-31
Audit Fees/Expenses
38,497 GBP2024-01-01 ~ 2024-12-31
8,238 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
512024-01-01 ~ 2024-12-31
662023-01-01 ~ 2023-12-31
Wages/Salaries
3,107,557 GBP2024-01-01 ~ 2024-12-31
3,792,088 GBP2023-01-01 ~ 2023-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
127,376 GBP2024-01-01 ~ 2024-12-31
145,421 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
3,556,505 GBP2024-01-01 ~ 2024-12-31
4,385,793 GBP2023-01-01 ~ 2023-12-31
Director Remuneration
407,510 GBP2024-01-01 ~ 2024-12-31
558,329 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-1,243 GBP2024-01-01 ~ 2024-12-31
0 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Computer software
790,598 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Land and buildings, Under hire purchased contracts or finance leases
45,710 GBP2023-12-31
Computers
933,572 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
979,282 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Under hire purchased contracts or finance leases
41,772 GBP2023-12-31
Computers
914,549 GBP2024-12-31
887,786 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
958,735 GBP2024-12-31
929,558 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings, Under hire purchased contracts or finance leases
2,414 GBP2024-01-01 ~ 2024-12-31
Computers
26,763 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
29,177 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Computers
19,023 GBP2024-12-31
45,786 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
751,148 GBP2024-12-31
3,363,030 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
1,587,291 GBP2024-12-31
990,176 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
0 GBP2024-12-31
17,531 GBP2023-12-31
Other Debtors
Current
55,200 GBP2024-12-31
11,835 GBP2023-12-31
Prepayments/Accrued Income
Current
761,070 GBP2024-12-31
1,867,558 GBP2023-12-31
Trade Creditors/Trade Payables
Current
325,625 GBP2024-12-31
498,808 GBP2023-12-31
Amounts owed to group undertakings
Current
1,095,418 GBP2024-12-31
923,418 GBP2023-12-31
Other Taxation & Social Security Payable
Current
114,519 GBP2024-12-31
151,476 GBP2023-12-31
Other Creditors
Current
7,740 GBP2024-12-31
0 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
1,220,443 GBP2024-12-31
2,440,802 GBP2023-12-31
Creditors
Current
2,763,745 GBP2024-12-31
4,014,504 GBP2023-12-31
Par Value of Share
Class 1 ordinary share
4 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
50,000 shares2024-12-31
50,000 shares2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
90,001 GBP2024-12-31
Between two and five year
107,858 GBP2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
197,859 GBP2024-12-31
  • QUANTICATE INTERNATIONAL LIMITED
    Info
    OXFORD PHARMACEUTICAL SCIENCES LTD. - 2008-01-05
    Registered number 03283749
    icon of addressBevan House, Bancroft Court, Hitchin, Hertfordshire SG5 1LH
    PRIVATE LIMITED COMPANY incorporated on 1996-11-26 (29 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-11-26
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.